论文部分内容阅读
目的探讨依那普利在肾病治疗中的临床应用效果。方法以2009年12月～2012年12月我院收治的肾病患者86例作为研究对象,依照诊断标准随机把患者分成观察组和对照组,每组43例。运用常规治疗方式治疗对照组,在常规治疗的基础上配合依那普利治疗观察组,观察与比较两组的临床治疗效果。结果治疗4～8周后,在肌酐、24h蛋白量及微球蛋白排泄率上,观察组明显低于对照组(P<0.05)。结论在治疗肾病当中,依那普利的治疗效果明显,可以对预后以及肾血流量进行改善,延缓病情进展,值得临床借鉴。
Objective To investigate the clinical effect of enalapril in the treatment of nephropathy. Methods Totally 86 patients with nephropathy admitted from December 2009 to December 2012 in our hospital were divided into observation group and control group according to the diagnostic criteria, with 43 cases in each group. The patients in the control group were treated with conventional treatment, and the enalapril treatment group was used on the basis of routine treatment. The clinical effects of the two groups were observed and compared. Results After 4 to 8 weeks of treatment, the levels of creatinine, 24h protein and microglobulin excretion in the observation group were significantly lower than those in the control group (P <0.05). Conclusion In the treatment of renal disease, enalapril treatment effect is obvious, can improve the prognosis and renal blood flow, delay the progression of the disease, it is worth learning from.